Clinical Trial Update: Impact of Biliopancreatic Limb Lenght on Long-term Weight Loss After Roux-en-Y Gastric Bypass [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether biliopancreatic limb length influences long-term weight loss after Roux-en-Y gastric bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Hospital General Universitario Elche | Conditions: Weight Loss | Phase 3 | Status: COMPLETED